export const StudyDesignContent = () => (
  <div className="study-design">
    <div className="max-width">
      <p><strong>PHASE 3 STUDY DESIGN:</strong> The efficacy of QIVIGY was evaluated in an open-label, prospective clinical study in adult patients with primary humoral immunodeficiency. A total of 47 patients receive intravenous infusion of QIVIGY at a dose of 266 mg/kg to 826 mg/kg on a 4-week (n=39) or a 3-week (n=8) infusion cycle for 12 months. There were no comparative head-to-head trials with QIVIGY.<sup>1</sup></p>
    </div>
  </div>
);